Guardant Health (GH) Is Up 8.3% After TRICARE Adds No-Copay Shield Coverage For Service Members

Earlier this week, Guardant Health announced that its FDA-approved Shield blood test for colorectal cancer screening is now ...
abc7NY

FDA approves blood test to detect colon cancer for those at 'average risk'

Guardant Health, Inc. announced the availability of Shield, the company's first blood-based test for the detection of early-stage colorectal cancer. automation The U.S. Food and Drug Administration on ...

Guardant Health

Guardant Health scientists have created the first blood-based test to screen for colorectal cancer that Medicare could cover. Guardant Health scientists have created the first blood-based test to ...
KTAL Shreveport on MSN

Tricare adds SHIELD blood test for Louisiana military cancer screening

Guardant Health's Shield blood test for colorectal cancer screening is now covered by TRICARE, providing active duty service ...

Guardant Health, Inc. (GH) Stock Forecasts

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
Morningstar

Shield CRC Blood Test Demonstrates Adherence of 95% in New Study of 20,000 Patients

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced new real-world data published in Current Medical Research and Opinion finding that the Shield blood-based ...

New Types of Tests That Can Change Healthcare

Guardant co-CEO Helmy Eltoukhy says the shift to personalized treatment and earlier diagnosis is here at the WIRED Health ...